Please find enclosed

September 30, 2026 BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400001 Scrip Code: 511509 Dear Sir/Madam, Subject : Proceedings/Outcome of the 39th Annual General Meeting (AGM) of the Company held on September 30, 2026 Reference : Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 We refer to our letter dated September 08, 2026, informing you that the 39th Annual General Meeting (‘AGM’) of the Members of the Company is scheduled through Video Conference (VC) / Other Audio-Visual Means (OAVM) on September 30, 2026. In this regard, we wish to inform that the 39th AGM was held on Wednesday, September 30, 2026, through VC/OAVM, in compliance with related circulars issued by Ministry of Corporate Affairs, Securities and Exchange Board of India (‘SEBI’) and other applicable provisions of the Companies Act, 2013 and in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the summary of proceedings/outcome of 39th AGM of the Company held on September 30, 2026. This is for your information and records. Thanking You, Yours faithfully For Vivo Bio Tech Limited Bhavish Vijayvargiya Company Secretary & Compliance Officer M.No. A77631 Encl. as above SUMMARY OF THE PROCEEDINGS/OUTCOME OF 39TH ANNUAL GENERAL MEETING OF VIVO BIO TECH LIMITED AS CONVENED ON WEDNESDAY, SEPTEMBER 30, 2026 AT 03.00 P.M. THROUGH VIDEO CONFERENCING (VC)/ OTHER AUDIO-VISUAL MEANS (OAVM). Members Present: Promoter - 01 Public - 66 Total - 67 Directors Present: 1. Mrs. Priya Rajender Goda - Non-Executive Chairperson - Independent Director & Chairman of Audit Committee and Stakeholders Relationship Committee 2. Mr. Kalyan Ram Mangipudi - Whole Time Director 3. Dr. S. Alangudi Whole Time Director 4. Mr. Sri Kalyan Kompella - Whole Time Director & CFO 5. Mr. Satyanarayana Vedula - Non-Independent Director 6. Mr. Shyam Sunder Tipparaju - Independent Director, Chairperson of Nomination & Remuneration Committee In Attendance: 1. Mr. Bhavish Vijayvargiya - Company Secretary 2. Mr. M. V. Joshi - Partner, P. Murali & Co, Statutory Auditors 3. Mr. G. Vinay Babu - Secretarial Auditor & Scrutinizer The 39th Annual General Meeting (AGM or Meeting) of the Members of the Vivo Bio Tech Limited (‘the Company’) was held on Wednesday, September 30, 2026, at 03:00 p.m. IST, through Video Conferencing (VC), in compliance with General Circular No. 09/2024 dated September 19, 2024, issued by the Ministry of Corporate Affairs (MCA) and Circular No. SEBI/HO/CFD/CFDPoD-2/P/CIR/2024/133 dated October 3, 2024 issued by SEBI (hereinafter collectively referred to as “the Circulars”) and other applicable provisions of the Companies Act, 2013. The meeting commenced at 03.00 p.m. Pursuant to the Articles of Association, Mrs. Priya Rajender Goda, Chairperson of the Board, chaired the Meeting and conducted the proceedings of the Meeting through VC. The requisite quorum being present, she called the Meeting to order. She further informed that since the Meeting was being held through VC, the proxy related procedures had been dispensed with. She then introduced the members of the Board, the Statutory Auditor and Secretarial Auditor. All the Directors were present at the AGM, including the Chairman of the Audit Committee, Nomination and Remuneration Committee and Stakeholders Relationship Committee. The Chairperson informed the Members that the statutory registers under the Companies Act, 2013 and Certificate obtained from the Secretarial Auditor of the Company confirming that the Company’s ESOP Schemes have been implemented in accordance with the SEBI Regulations and in accordance with the resolutions passed by the Shareholders, were available to the Members for inspection in electronic form. The Chairperson then delivered her speech and Mr. Satyanarayana Vedula, Director of the Company deliberated on the business and performance highlights of the Company. The Notice dated August 22, 2026, convening the AGM was taken as read. As the Auditors Report did not have any qualifications or observations, the same was not read out at the Meeting. The following items of business as set out in the Notice convening the AGM (‘Notice’) were transacted at the AGM: 1. To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, the Report of the Auditors’ thereon and the Report of the Board of Directors. 2. To appoint a Director in place of Mr. Kalyan Ram Mangipudi (DIN: 02012580) who retires by rotation, and being eligible, offers himself for re-appointment. 3. Re-appointment of Mr. Sri Kalyan Kompella (DIN: 03137506) as the Whole-time Director of the Company. 4. Re-appointment of Dr. Sankaranarayanan Alangudi (DIN: 02703392) as the Whole-time Director of the Company. The Chairperson, also informed the following:  The Company had provided remote e-voting facility to enable Members to cast their votes electronically on all above 4 items of business as set out in the Notice. The Chairperson informed that remote e-voting commenced at 9:00 a.m. (IST) on Sunday, September 27, 2026, and concluded at 5:00 p.m. (IST) on Tuesday, September 29, 2026.  Mr. G. Vinay, Practising Company Secretary was appointed as the Scrutinizer for conducting the remote e-Voting and e-Voting process at the AGM.  Voting results, i.e., remote e-Voting and e-Voting at the AGM would be disseminated to the stock exchanges and also uploaded on the website of the Company and on e-Voting platform of Central Depository Services (India) Limited (CDSL) on or before October 03, 2026. The Chairperson invited the Members who had registered as speakers to speak / ask questions or express their views. The Members who had registered as speakers expressed their views and raised a few questions. Mr. Satyanarayana V and Mr. Sri Kalyan K, Directors replied to the queries and provided necessary clarifications to the Members. The facility to vote at the meeting on all the 4 items of business, as set out in the Notice, through electronic voting system of CDSL, was also made available to those Members who participated in the Meeting and had not cast their votes through remote e-Voting. The Chairperson concluded the meeting at 04:02 p.m., instructed the moderator to keep the e-Voting window open for 15 minutes and requested the members to cast their vote. As per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 submitting the details in the enclosed annexure with regard to re-appointment of Mr. Kalyan Ram Mangipudi, Mr. Sri Kalyan Kompella and Dr. Sankaranarayanan Alangudi. ***** Annexure Disclosure of information pursuant to Regulation 30 the SEBI Listing Regulations read with Schedule III thereto and the SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January 2026. S.No Particular Details Mr. Sri Kalyan Kompella Dr. Sankaranarayanan Mr. Kalyan Ram Alangudi Mangipudi 1. Reason for change viz. Re-appointment No Change. Mr. appointment, reappointment, Kalyan Ram resignation, removal, death or Mangipudi who otherwise retires by rotation and being eligible, has offered himself for reappointment 2. Date of appointment/re Appointed on August 22, Appointed on August Not Applicable appointment/cessation(as 2026 for a period of five 22, 2026 for a period of applicable) & term of (5) consecutive years i.e five (5) consecutive appointment/reappointment; November 03, 2026 until years i.e January 06, November 02, 2031 2027 until January 05, subject to approval of the 2032 subject to members at the ensuing approval of the Annual General Meeting members at the ensuing Annual General Meeting 3. Brief Profile Mr. K. Kalyan has 25 plus Dr. Sankaranarayanan Mr. M. Kalyan Ram (In case of Appointment) years of experience in the is a discovery biologist has 23 plus years of field of Accounting, and scie [Showing first 8,000 characters — download PDF for full document]